Kerry Savage

Kerry Savage

British Columbia Cancer Agency - Vancouver / Canada
Others
AD Scientific Index ID: 5275924
person_outline Kerry Savage's MOST POPULAR ARTICLES
1-) Nivolumab in Previously Untreated Melanoma without BRAF MutationC Robert, GV Long, B Brady, C Dutriaux, M Maio, L Mortier, JC Hassel, ...New England journal of medicine 372 (4), 320-330, 201553092015
2-) Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin\\\'s lymphomaA Younes, AK Gopal, SE Smith, SM Ansell, JD Rosenblatt, KJ Savage, ...Journal of clinical oncology 30 (18), 2183, 201215792012
3-) The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOPLH Sehn, B Berry, M Chhanabhai, C Fitzgerald, K Gill, P Hoskins, R Klasa, ...Blood 109 (5), 1857-1861, 200714872007
4-) Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisoneNA Johnson, GW Slack, KJ Savage, JM Connors, S Ben-Neriah, S Rogic, ...Journal of clinical oncology 30 (28), 3452-3459, 201211502012
5-) The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphomaKJ Savage, S Monti, JL Kutok, G Cattoretti, D Neuberg, L De Leval, ...Blood 102 (12), 3871-3879, 200310522003